WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that a new Global Responsibility section has been launched as part of Incyte.com. This section provides information on Incyte’s long-term approach and commitment to building a sustainable business by helping patients in need, supporting its colleagues, giving back to its communities, reducing its impact on the environment and promoting ethical and responsible behavior.
In addition, and as part of this newly available content, Incyte has also released its first annual Sustainable Accounting Standards Board (SASB) Summary as well as a summary of 2019 Global Responsibility Highlights.
“We are proud to have formalized our Global Responsibility initiative. The first phase of this project has been to improve our public disclosure of our ongoing environmental, social and governance (ESG) efforts,” said Hervé Hoppenot, Chief Executive Officer, Incyte. “Our Executive Leadership team will set specific priorities and goals for the next phase of our Global Responsibility initiative, and we look forward to keeping you informed on our progress.”
To learn more, visit Incyte.com/Responsibility or contact the Incyte Global Responsibility team at globalresponsibility@incyte.com.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
Forward-Looking Statements
Except for the historical information set forth herein, the matters set forth in this press release, as well as the materials referenced on our corporate website, Incyte.com, including statements regarding whether the Company will achieve its global responsibility goals set forth in these materials or build a sustainable business, contain predictions, estimates and other forward-looking statements. These forward-looking statements are based on the Company’s current expectations and subject to risks and uncertainties that may cause actual results to differ materially, which risks are detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2019 and its Form 10-Q for the quarter ended March 31, 2020. The Company disclaims any intent or obligation to update these forward-looking statements.
# # #
